➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Johnson and Johnson
Moodys
AstraZeneca
Merck

Last Updated: September 20, 2021

DrugPatentWatch Database Preview

Oxymetazoline hydrochloride; tetracaine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for oxymetazoline hydrochloride; tetracaine hydrochloride and what is the scope of freedom to operate?

Oxymetazoline hydrochloride; tetracaine hydrochloride is the generic ingredient in one branded drug marketed by St Renatus and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Oxymetazoline hydrochloride; tetracaine hydrochloride has twenty-five patent family members in fifteen countries.

There are three drug master file entries for oxymetazoline hydrochloride; tetracaine hydrochloride.

Summary for oxymetazoline hydrochloride; tetracaine hydrochloride
International Patents:25
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 3
Clinical Trials: 7
DailyMed Link:oxymetazoline hydrochloride; tetracaine hydrochloride at DailyMed
Recent Clinical Trials for oxymetazoline hydrochloride; tetracaine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of North Carolina, Chapel HillPhase 4
Dow University of Health SciencesEarly Phase 1
Analytical Bio-Chemistry Laboratories, Inc.Phase 2

See all oxymetazoline hydrochloride; tetracaine hydrochloride clinical trials

US Patents and Regulatory Information for oxymetazoline hydrochloride; tetracaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
St Renatus KOVANAZE oxymetazoline hydrochloride; tetracaine hydrochloride SPRAY, METERED;NASAL 208032-001 Jun 29, 2016 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
St Renatus KOVANAZE oxymetazoline hydrochloride; tetracaine hydrochloride SPRAY, METERED;NASAL 208032-001 Jun 29, 2016 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Johnson and Johnson
Moodys
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.